APOPTOSIS AND PROGRAMMED CELL-DEATH IN IMMUNITY

被引:261
作者
COHEN, JJ
DUKE, RC
FADOK, VA
SELLINS, KS
机构
[1] NATL JEWISH CTR IMMUNOL & RESP MED, DENVER, CO 80206 USA
[2] BARBARA DAVIS CTR CHILDHOOD DIABET, DENVER, CO 80262 USA
关键词
APOPTOSIS; DNA FRAGMENTATION; CELL DEATH; GLUCOCORTICOIDS; ACTIVATION-INDUCED DEATH; CTL;
D O I
10.1146/annurev.immunol.10.1.267
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Death of some cells in the mammalian body is clearly programmed. In the immune system there are many examples of programmed cell death, during development of lymphocytes as well as at later stages, after interaction with antigen. Many of these examples display the morphology of apoptosis: They undergo shrinkage and zeiosis, the nucleus collapses, and chromatin is cleaved into nucleosomal fragments. The cell is rapidly recognized by phagocytes and disposed of without releasing its contents. In some but not all cases of apoptosis, new macromolecular synthesis is required. Cytotoxic T cells induce changes in their targets that are morphologically apoptotic. The mechanism of apoptosis is currently under active investigation.
引用
收藏
页码:267 / 293
页数:27
相关论文
共 172 条
  • [1] AFANASEV VN, 1988, TSITOLOGIYA+, V30, P1108
  • [2] Allan D.J., 1987, P229
  • [3] ALLAN DJ, 1986, SCAN ELECTRON MICROS, V1986, P1121
  • [4] PHOSPHATIDYLSERINE AS A DETERMINANT OF RETICULOENDOTHELIAL RECOGNITION OF LIPOSOME MODELS OF THE ERYTHROCYTE SURFACE
    ALLEN, TM
    WILLIAMSON, P
    SCHLEGEL, RA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (21) : 8067 - 8071
  • [5] APOPTOSIS - A GENERAL COMMENT
    ALLES, A
    ALLEY, K
    BARRETT, JC
    BUTTYAN, R
    COLUMBANO, A
    COPE, FO
    COPELAN, EA
    DUKE, RC
    FAREL, PB
    GERSHENSON, LE
    GOLDGABER, D
    GREEN, DR
    HONN, KV
    HULLY, J
    ISAACS, JT
    KERR, JFR
    KRAMMER, PH
    LOCKSHIN, RA
    MARTIN, DP
    MCCONKEY, DJ
    MICHAELSON, J
    SCHULTEHERMANN, R
    SERVER, AC
    SZENDE, B
    TOMEI, LD
    TRITTON, TR
    UMANSKY, SR
    VALERIE, K
    WARNER, HR
    [J]. FASEB JOURNAL, 1991, 5 (08) : 2127 - 2128
  • [6] ALNEMRI ES, 1989, J BIOL CHEM, V264, P4104
  • [7] AMEISEN JC, 1991, IMMUNOL TODAY, V12, P102
  • [8] AMENTA JS, 1989, RBC-CELL BIOL REV, V21, P401
  • [9] Anderson R E, 1976, Adv Immunol, V24, P215, DOI 10.1016/S0065-2776(08)60331-4
  • [10] ARENDS MJ, 1990, AM J PATHOL, V136, P593